140 related articles for article (PubMed ID: 23867387)
1. Design, synthesis and structure-activity relationships of some novel, highly potent anti-invasive (E)- and (Z)-stilbenes.
Roman BI; De Coen LM; Thérèse F C Mortier S; De Ryck T; Vanhoecke BW; Katritzky AR; Bracke ME; Stevens CV
Bioorg Med Chem; 2013 Sep; 21(17):5054-63. PubMed ID: 23867387
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the SAR of anti-invasive chalcones: synthesis and biological evaluation of conformationally restricted analogues.
Roman BI; Ryck TD; Dierickx L; Vanhoecke BW; Katritzky AR; Bracke M; Stevens CV
Bioorg Med Chem; 2012 Aug; 20(15):4812-9. PubMed ID: 22743088
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Multifunctional Hybrid Analogs for Stilbenes, Chalcones and Flavanones.
Cagir A; Odaci B; Varol M; Akcok I; Okur O; Koparal AT
Anticancer Agents Med Chem; 2018 Feb; 17(14):1915-1923. PubMed ID: 28554313
[TBL] [Abstract][Full Text] [Related]
4. Further studies on anti-invasive chemotypes: An excursion from chalcones to curcuminoids.
Roman BI; De Ryck T; Verhasselt S; Bracke ME; Stevens CV
Bioorg Med Chem Lett; 2015 Mar; 25(5):1021-5. PubMed ID: 25666820
[TBL] [Abstract][Full Text] [Related]
5. Stilbene-chalcone hybrids: design, synthesis, and evaluation as a new class of antimalarial scaffolds that trigger cell death through stage specific apoptosis.
Sharma N; Mohanakrishnan D; Shard A; Sharma A; Saima ; Sinha AK; Sahal D
J Med Chem; 2012 Jan; 55(1):297-311. PubMed ID: 22098429
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
7. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antitumor evaluation, and apoptosis-inducing activity of hydroxylated (E)-stilbenes.
Lion CJ; Matthews CS; Stevens MF; Westwell AD
J Med Chem; 2005 Feb; 48(4):1292-5. PubMed ID: 15715501
[TBL] [Abstract][Full Text] [Related]
9. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents.
Reddy MV; Su CR; Chiou WF; Liu YN; Chen RY; Bastow KF; Lee KH; Wu TS
Bioorg Med Chem; 2008 Aug; 16(15):7358-70. PubMed ID: 18602831
[TBL] [Abstract][Full Text] [Related]
11. Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism.
Simoni D; Roberti M; Invidiata FP; Aiello E; Aiello S; Marchetti P; Baruchello R; Eleopra M; Di Cristina A; Grimaudo S; Gebbia N; Crosta L; Dieli F; Tolomeo M
Bioorg Med Chem Lett; 2006 Jun; 16(12):3245-8. PubMed ID: 16580204
[TBL] [Abstract][Full Text] [Related]
12. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
[TBL] [Abstract][Full Text] [Related]
13. From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties.
Buscató E; Büttner D; Brüggerhoff A; Klingler FM; Weber J; Scholz B; Zivković A; Marschalek R; Stark H; Steinhilber D; Bode HB; Proschak E
ChemMedChem; 2013 Jun; 8(6):919-23. PubMed ID: 23596124
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of Novel Imine Stilbene Analogs Exhibiting Potent Anticancer Activity.
Naini R; Ravikumar E; Singh SS; Kancha RK; Rao KV; Reddy VD
Anticancer Agents Med Chem; 2017 Nov; 17(11):1537-1544. PubMed ID: 28356012
[TBL] [Abstract][Full Text] [Related]
15. Syntheses and potential anti-prostate cancer activities of ionone-based chalcones.
Zhou J; Geng G; Batist G; Wu JH
Bioorg Med Chem Lett; 2009 Feb; 19(4):1183-6. PubMed ID: 19138519
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticancer activity of N-substituted 2-arylquinazolinones bearing trans-stilbene scaffold.
Mahdavi M; Pedrood K; Safavi M; Saeedi M; Pordeli M; Ardestani SK; Emami S; Adib M; Foroumadi A; Shafiee A
Eur J Med Chem; 2015 May; 95():492-9. PubMed ID: 25847767
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of stilbene-based pure estrogen antagonists.
Walter G; Liebl R; von Angerer E
Bioorg Med Chem Lett; 2004 Sep; 14(18):4659-63. PubMed ID: 15324884
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacological effect.
Vogel S; Barbic M; Jürgenliemk G; Heilmann J
Eur J Med Chem; 2010 Jun; 45(6):2206-13. PubMed ID: 20153559
[TBL] [Abstract][Full Text] [Related]
19. Rapid synthesis of triazole-modified resveratrol analogues via click chemistry.
Pagliai F; Pirali T; Del Grosso E; Di Brisco R; Tron GC; Sorba G; Genazzani AA
J Med Chem; 2006 Jan; 49(2):467-70. PubMed ID: 16420033
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxic evaluation of a series of resveratrol derivatives modified in C2 position.
Huang XF; Ruan BF; Wang XT; Xu C; Ge HM; Zhu HL; Tan RX
Eur J Med Chem; 2007 Feb; 42(2):263-7. PubMed ID: 17000031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
